Please see below for a list of search results.
Our Codes of Practice and Standards provide practical guidance to professionals carrying out activities within the scope of the HTA's remit.
Only authorised users can use the HTA Portal to securely submit their 2020 annual activity data.
This document sets out the strategy for the Human Tissue Authority (HTA). It describes our strategic approach and direction, key challenges and opportunities, our strategic objectives and how we will deploy our resources on the priority areas identified over the next three...
All establishments in the Human Application sector must follow the HTA’s Guide to Quality and Safety Assurance for Tissue and Cells for Patient Treatment.
This guide explains the requirements for:
During this period, it is likely that Human Application (HA) establishments will have to adapt quickly to changing circumstances, whether as a result of staffing or supply chain issues.
IAs are automatically reaccredited unless a need for refresher training is identified through the monthly performance assessment process.
IAs will be assessed on the basis of two criteria:
1. Quantitative assessment (annual)
From 1 January 2021 there will be a six-month phase to allow Human Application sector establishments time to comply with any new UK import and export licensing requirements. Licence variations must be in place by 30 June 2021.
The HTA’s HA licensing standard, GQ2c, requires an audit to be conducted in an independent manner at least every two years. We do this to verify compliance with protocols and HTA standards and that any findings and corrective actions are documented.